nach oben

European Journal of Nutrition

Erschienen in:

26.08.2021 | Review

Emerging cardioprotective mechanisms of vitamin B6: a narrative review

verfasst von: Thanutchaporn Kumrungsee, Peipei Zhang, Noriyuki Yanaka, Takashi Suda, Norihisa Kato

Erschienen in: European Journal of Nutrition | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Although overt vitamin B6 deficiency is rare, marginal vitamin B6 deficiency is frequent and occurs in a consistent proportion of the population. The marginal vitamin B6 deficiency appears to relate to an increased risk of inflammation-related diseases, such as cardiovascular diseases and cancers. Of all the cardiovascular diseases, heart failure is a complex clinical syndrome associated with a high mortality rate. So far, information regarding the cardioprotective mechanisms of vitamin B6 has been limited. Meanwhile, recent studies have revealed that vitamin B6 treatment increases cardiac levels of imidazole dipeptides (e.g., carnosine, anserine, and homocarnosine), histamine, and γ-aminobutyric acid (GABA) and suppresses P2X7 receptor-mediated NLRP3 inflammasome. These modulations may imply potential cardioprotective mechanisms of vitamin B6. These modulations may also be involved in the underlying mechanisms through which vitamin B6 suppresses oxidative stress and inflammation. This review provides an up-to-date evaluation of our current understanding of the cardioprotective mechanisms of vitamin B6.

Morris MS, Picciano MF, Jacques PF, Selhub J (2008) Plasma pyridoxal 5’-phosphate in the US population: the National health and nutrition examination survey, 2003–2004. Am J Clin Nutr 87:1446–1454. https://doi.org/10.1093/ajcn/87.5.1446CrossRefPubMed

Troesch B, Hoeft B, McBurney M, Eggersdorfer M, Weber P (2012) Dietary surveys indicate vitamin intakes below recommendations are common in representative Western countries. Br J Nutr 108:692–698. https://doi.org/10.1017/S0007114512001808CrossRefPubMed

Ho C-L, Quay TAW, Devlin AM, Lamers Y (2016) Prevalence and predictors of low vitamin B6 status in healthy young adult women in metro vancouver. Nutrients 8:538. https://doi.org/10.3390/nu8090538CrossRefPubMedCentral

Hellmann H, Mooney S (2010) Vitamin B₆: A Molecule for Human Health? Molecules 15:442–1459. https://doi.org/10.3390/molecules15010442CrossRefPubMedPubMedCentral

Zhang P, Suda T, Suidasari S, Kumrungsee T, Yanaka N, Kato N (2020) Novel preventive mechanisms of vitamin B6 against inflammation, inflammasome, and chronic diseases. In: Vinood BP, editor. Molecular Nutrition, New York: Academic Press, 283–299. https://doi.org/10.1016/B978-0-12-811907-5.00032-4

Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB et al (2013) American heart association statistics c, stroke statistics s. heart disease and stroke statistics–2013 update: a report from the american heart association. Circulation 127:e6–e245. https://doi.org/10.1161/CIR.0b013e31828124adCrossRefPubMed

Pusceddu I, Herrmann W, Kleber ME, Scharnagl H, Hoffmann MM, Winklhofer-Roob BM et al (2020) Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study. Eur J Nutr 59:1399–1411. https://doi.org/10.1007/s00394-019-01993-8CrossRefPubMed

Minović I, Kieneker LM, Gansevoort RT, Eggersdorfer M, Touw DJ, Voerman AJ et al (2020) Vitamin B6, inflammation, and cardiovascular outcome in a population-based cohort: the prevention of renal and vascular end-stage disease (PREVEND) study. Nutrients 12:2711. https://doi.org/10.3390/nu12092711CrossRefPubMedCentral

Jeon J, Park K (2019) Dietary Vitamin B₆ intake associated with a decreased risk of cardiovascular disease: a prospective cohort study. Nutrients 11:1484. https://doi.org/10.3390/nu11071484CrossRefPubMedCentral

10.

Zhao L-G, Shu X-O, Li H-L, Gao J, Han L-H, Wang J et al (2019) Prospective cohort studies of dietary vitamin B6 intake and risk of cause-specific mortality. Clin Nutr 38:1180e–1187e. https://doi.org/10.1016/j.clnu.2018.04.016CrossRef

11.

Jayedi A, Zargar MS (2019) Intake of vitamin B6, folate, and vitamin B12 and risk of coronary heart disease: a systematic review and dose-response meta-analysis of prospective cohort studies. Crit Rev Food Sci Nutr 59:2697–2707. https://doi.org/10.1080/10408398.2018.1511967CrossRefPubMed

12.

Jenkins DJ, Spence JD, Giovannucci EL, Kim YI, Josse R, Vieth R et al (2018) Supplemental vitamins and minerals for CVD prevention and treatment. J Am Coll Cardiol 71:2570–2584. https://doi.org/10.1016/j.jacc.2018.04.020CrossRefPubMed

13.

Kim J, Choi J, Kwon SY, McEvoy JW, Blaha MJ, Blumenthal RS et al (2018) Association of multivitamin and mineral supplementation and risk of cardiovascular disease. a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 11:e004224. https://doi.org/10.1161/CIRCOUTCOMES.117.004224CrossRefPubMed

14.

Tardif JC, Carrier M, Kandzari DE, Emery R, Cote R, Heinonen T et al (2007) Effects of pyridoxal-5’-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study. J Thorac Cardiovasc Surg 133:1604–1611. https://doi.org/10.1016/j.jtcvs.2007.01.049CrossRefPubMed

15.

Dhalla NS, Takeda S, Elimban V (2013) Mechanisms of the beneficial effects of vitamin B6 and pyridoxal 5’-phosphate on cardiac performance in ischemic heart disease. Clin Chem Lab Med 51:535–543. https://doi.org/10.1515/cclm-2012-0553CrossRefPubMed

16.

Paganelli F, Mottola G, Fromonot J, Marlinge M, Deharo P, Guieu R et al (2021) Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link? Int J Mol Sci 22:1690. https://doi.org/10.3390/ijms22041690CrossRefPubMedPubMedCentral

17.

Ubbink JB, van der Merwe A, Delport R, Allen RH, Stabler SP, Riezler R et al (1996) The effect of a subnormal vitamin B-6 status on homocysteine metabolism. J Clin Invest 98:177–184. https://doi.org/10.1172/JCI118763CrossRefPubMedPubMedCentral

18.

Shen J, Lai C-Q, Mattei J, Ordovas JM, Tucker KL (2010) Association of vitamin B-6 status with inflammation, oxidative stress, and chronic inflammatory conditions: the Boston Puerto Rican Health Study. Am J Clin Nutr 91:337–342. https://doi.org/10.3945/ajcn.2009.28571CrossRefPubMed

19.

Wang Q, Liu D, Song P, Zou MH (2015) Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation. Front Biosci 20:1116–1143. https://doi.org/10.2741/4363CrossRef

20.

Yanaka N, Koyama TA, Komatsu S, Nakamura E, Kanda M, Kato N (2005) Vitamin B6 suppresses NF-kappaB activation in LPS-stimulated mouse macrophages. Int J Mol Med 16:1071–1075. https://doi.org/10.3892/ijmm.16.6.1071CrossRefPubMed

21.

Zhang P, Tsuchiya K, Kinoshita T, Kushiyama H, Suidasari S, Hatakeyama M et al (2016) Vitamin B6 prevents IL-1 beta protein production by inhibiting NLRP3 inflammasome activation. J Biol Chem 291:24517–24527. https://doi.org/10.1074/jbc.M116.743815CrossRefPubMedPubMedCentral

22.

Shen J, Lai C, Mattei J, Ordovas JM, Tucker KL (2009) Association of vitamin B-6 status with inflammation, oxidative stress, and chronic inflammatory conditions: the Boston Puerto Rican Health Study. Am J Clin Nutr 91:337–342. https://doi.org/10.3945/ajcn.2009.28571CrossRefPubMedPubMedCentral

23.

Kuwahara K, Nanri A, Pham NM, Kurotani K, Kume A, Sato M et al (2013) Serum vitamin B6, folate, and homocysteine concentrations and oxidative DNA damage in Japanese men and women. Nutrition 29:1219–1223. https://doi.org/10.1016/j.nut.2013.03.014CrossRefPubMed

24.

Matxain JM, Padro D, Ristilä M, Strid A, Eriksson LA (2009) Evidence of high OH radical quenching efficiency by vitamin B₆. J Phys Chem B 113:9629–9632. https://doi.org/10.1021/jp903023cCrossRefPubMed

25.

Mahfouz MM, Zhou SQ, Kummerow FA (2009) Vitamin B6 compounds are capable of reducing the superoxide radical and lipid peroxide levels induced by H₂O₂ in vascular endothelial cells in culture. Inter J Vit Nutr Res 79:218–229. https://doi.org/10.1024/0300-9831.79.4.218CrossRef

26.

Kumrungsee T, Nirmagustina DE, Arima T, Onishi K, Sato K, Kato N et al (2019) Novel metabolic disturbances in marginal vitamin B₆-deficient rat heart. J Nutr Biochem 65:26–34. https://doi.org/10.1016/j.jnutbio.2018.11.004CrossRefPubMed

27.

Suidasari S, Hasegawa T, Yanaka N, Kato N (2015) Dietary supplemental vitamin B6 increases carnosine and anserine concentrations in the heart of rats. Springerplus 4:280. https://doi.org/10.1186/s40064-015-1074-8CrossRefPubMedPubMedCentral

28.

Suidasari S, Stautemas J, Uragami S, Yanaka N, Derave W, Kato N (2016) Carnosine content in skeletal muscle is dependent on Vitamin B6 status in rats. Front Nutr 2:39. https://doi.org/10.3389/fnut.2015.00039CrossRefPubMedPubMedCentral

29.

Lombardi C, Carubelli V, Lazzarini V, Vizzardi E, Bordonali T, Ciccarese C et al (2015) Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure. Nutrition 31:72–78. https://doi.org/10.1016/j.nut.2014.04.021CrossRefPubMed

30.

Boldyrev AA, Aldini G, Derave W (2013) Physiology and pathophysiology of carnosine. Physiol Rev 93:1803–1845. https://doi.org/10.1152/physrev.00039.2012CrossRefPubMed

31.

Hipkiss AR (2009) Carnosine and its possible roles in nutrition and health. Adv Food Nutr Res 57:87–154. https://doi.org/10.1016/S1043-4526(09)57003-9CrossRefPubMed

32.

Attanà P, Lazzeri C, Picariello C, Dini CS, Gensini GF, Valente S (2012) Lactate and lactate clearance in acute cardiac care patients. Eur Heart J Acute Cardiovasc Care 1:115–121. https://doi.org/10.1177/2048872612451168CrossRefPubMedPubMedCentral

33.

Evran B, KarpuzoÊlu H, Develi S, Kalaz EB, Soluk-TekkeÎin M, Olgaç V et al (2014) Effects of carnosine on prooxidant-antioxidant status in heart tissue, plasma and erythrocytes of rats with isoproterenol-induced myocardial infarction. Pharmacol Rep 66:81–86. https://doi.org/10.1016/j.pharep.2013.08.008CrossRefPubMed

34.

Zhao J, Posa DK, Kumar V, Hoetker D, Kumar A, Ganesan S et al (2019) Carnosine protects cardiac myocytes against lipid peroxidation products. Amino Acids 51:123–138. https://doi.org/10.1007/s00726-018-2676-6CrossRefPubMed

35.

Zhao J, Conklin DJ, Guo Y, Zhang X, Obal D, Guo L et al (2020) Cardiospecific Overexpression of ATPGD1 (Carnosine Synthase) Increases Histidine Dipeptide Levels and Prevents Myocardial Ischemia Reperfusion Injury. J Am Heart Assoc 9:e015222. https://doi.org/10.1161/JAHA.119.015222CrossRefPubMedPubMedCentral

36.

Fresta CG, Fidilio A, Lazzarino G, Musso N, Grasso M, Merlo S et al (2020) Modulation of pro-oxidant and pro-inflammatory activities of m1 macrophages by the natural dipeptide carnosine. Int J Mol Sci 21:776. https://doi.org/10.3390/ijms21030776CrossRefPubMedCentral

37.

Tucker WJ, Haykowsky MJ, Seo Y, Stehling E, Forman DE (2018) Impaired exercise tolerance in heart failure: role of skeletal muscle morphology and function. Curr Heart Fail Rep 15:323–331. https://doi.org/10.1007/s11897-018-0408-6CrossRefPubMedPubMedCentral

38.

Suzuki T, Palus S, Springer J (2018) Skeletal muscle wasting in chronic heart failure. ESC Heart Failure 5:1099–1107. https://doi.org/10.1002/ehf2.12387CrossRefPubMedPubMedCentral

39.

Springer J, Springer J-I, Anker SD (2017) Muscle wasting and sarcopenia in heart failure and beyond: update 2017. ESC Heart Failure 4:492–498. https://doi.org/10.1002/ehf2.12237CrossRefPubMedPubMedCentral

40.

Curcio F, Testa G, Liguori I, Papillo M, Flocco V, Panicara V et al (2020) Sarcopenia and Heart Failure. Nutrients 12:211. https://doi.org/10.3390/nu12010211CrossRefPubMedCentral

41.

Ganapathy A, Nieves JW (2020) Nutrition and sarcopenia—what do we know? Nutrients 12:1755. https://doi.org/10.3390/nu12061755CrossRefPubMedCentral

42.

Suidasari S, Uragami S, Yanaka N, Kato N (2017) Dietary vitamin B6 modulates the gene expression of myokines, Nrf2-related factors, myogenin and HSP60 in the skeletal muscle of rats. Exp Ther Med 14:3239–3246. https://doi.org/10.3892/etm.2017.4879CrossRefPubMedPubMedCentral

43.

Kumar A, Kumar Y, Sevak JK, Kumar S, Kumar N, Gopinath SD (2020) Metabolomic analysis of primary human skeletal muscle cells during myogenic progression. Sci Rep 10:11824. https://doi.org/10.1038/s41598-020-68796-4CrossRefPubMedPubMedCentral

44.

de Courten B, Kurdiova T, de Courten MP, Belan V, Everaert I, Vician M et al (2015) Muscle carnosine is associated with cardiometabolic risk factors in humans. PLoS One 10:e0138707. https://doi.org/10.1371/journal.pone.0138707CrossRefPubMedPubMedCentral

45.

Flancbaum L, Fitzpatrick JC, Brotman DN, Marcoux AM, Kasziba E, Fisher H (1990) The presence and significance of carnosine in histamine-containing tissues of several mammalian species. Agents Actions 31:190–196. https://doi.org/10.1007/BF01997607CrossRefPubMed

46.

Deng L, Hong T, Lin J, Ding S, Huang Z, Chen J et al (2015) Histamine deficiency exacerbates myocardial injury in acute myocardial infarction through impaired macrophage infiltration and increased cardiomyocyte apoptosis. Sci Rep 5:13131. https://doi.org/10.1038/srep13131CrossRefPubMedPubMedCentral

47.

Noguchi K, Ishida J, Kim J-D, Muromachi N, Kako K, Mizukami H et al (2020) Histamine receptor agonist alleviates severe cardiorenal damages by eliciting anti-inflammatory programming. Proc Natl Acad Sci 117:3150–3156. https://doi.org/10.1073/pnas.1909124117CrossRefPubMedPubMedCentral

48.

Li L, Li G, Sheng S, Yin D (2005) Substantial reaction between histamine and malondialdehyde: a new observation of carbonyl stress. Neuro Endocrinol Lett 26:799–805PubMed

49.

Deng Y, Wang W, Yu P, Xi Z, Xu L, Li X et al (2013) Comparison of taurine, GABA, Glu, and Asp as scavengers of malondialdehyde in vitro and in vivo. Nanoscale Res Lett 8:190. https://doi.org/10.1186/1556-276X-8-190CrossRefPubMedPubMedCentral

50.

Han D, Kim HY, Lee HJ, Shim I, Hahm DH (2007) Wound healing activity of gamma-aminobutyric acid (GABA) in rats. J Microbiol Biotechnol 17:1661–1669PubMed

51.

Chen C, Zhou X, He J, Xie Z, Xia S, Lu G (2019) The roles of GABA in ischemia-reperfusion injury in the central nervous system and peripheral organs. Oxid Med Cell Longev 2019:4028394. https://doi.org/10.1155/2019/4028394CrossRefPubMedPubMedCentral

52.

Bayoumi RA, Kirwan JR, Smith WRD (1972) Some effects of dietary vitamin B6 deficiency and 4-deoxypyridoxine on γ-aminobutyric acid metabolism in rat brain. J Neurochem 19:569–576. https://doi.org/10.1111/j.1471-4159.1972.tb01374.xCrossRefPubMed

53.

Schroder K, Tschopp J (2010) The inflammasomes. Cell 140:821–832. https://doi.org/10.1016/j.cell.2010.01.040CrossRefPubMed

54.

Ding J, Wang K, Liu W, She Y, Sun Q, Shi J et al (2016) Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535:111–116. https://doi.org/10.1038/nature18590CrossRefPubMed

55.

He WT, Wan H, Hu L, Chen P, Wang X, Huang Z et al (2015) Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. Cell Res 25:1285–1298. https://doi.org/10.1038/cr.2015.139CrossRefPubMedPubMedCentral

56.

Takahashi M (2014) NLRP3 inflammasome as a novel player in myocardial infarction. Int Heart J 55:101–105. https://doi.org/10.1536/ihj.13-388CrossRefPubMed

57.

Butts B, Gary RA, Dunbar SB, Butler J (2015) The importance of NLRP3 inflammasome in heart failure. J Card Fail 21:586–593. https://doi.org/10.1016/j.cardfail.2015.04.014CrossRefPubMedPubMedCentral

58.

Mezzaroma E, Toldo S, Farkas D, Seropian IM, Van Tassell BW, Salloum FN et al (2011) The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. Proc Natl Acad Sci 108:19725–19730. https://doi.org/10.1073/pnas.1108586108CrossRefPubMedPubMedCentral

59.

Pomerantz BJ, Reznikov LL, Harken AH, Dinarello CA (2001) Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1β. Proc Natl Acad Sci 98:2871–2876. https://doi.org/10.1073/pnas.041611398CrossRefPubMedPubMedCentral

60.

Bracey NA, Beck PL, Muruve DA, Hirota SA, Guo J, Jabagi H et al (2013) The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1β. Exp Physiol 98:462–472. https://doi.org/10.1113/expphysiol.2012.068338CrossRefPubMed

61.

Abbate A, Toldo S, Marchetti C, Kron J, Van Tassell BW, Dinarello CA (2020) Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease. Circ Res 126:1260–1280. https://doi.org/10.1161/CIRCRESAHA.120.315937CrossRefPubMedPubMedCentral

62.

Sokolova M, Sjaastad I, Louwe MC, Alfsnes K, Aronsen JM, Zhang L et al (2019) NLRP3 inflammasome promotes myocardial remodeling during diet-induced obesity. Front Immunol 10:1621. https://doi.org/10.3389/fimmu.2019.01621CrossRefPubMedPubMedCentral

63.

LaRock DL, Sands JS, Ettouati E, Richard M, Bushway PJ, Adler ED et al (2019) Inflammasome inhibition blocks cardiac glycoside cell toxicity. J Biol Chem 294:12846–12854. https://doi.org/10.1074/jbc.RA119.008330CrossRefPubMedPubMedCentral

64.

Marín-Aguilar F, Lechuga-Vieco AV, Alcocer-Gómez E, Castejón-Vega B, Lucas J, Garrido C et al (2020) NLRP3 inflammasome suppression improves longevity and prevents cardiac aging in male mice. Aging Cell 19:e13050. https://doi.org/10.1111/acel.13050CrossRefPubMed

65.

Toldo S, Abbate A (2018) The NLRP3 inflammasome in acute myocardial infarction. Nat Rev Cardiol 15:203–214. https://doi.org/10.1038/nrcardio.2017.161CrossRefPubMed

66.

Lim GB (2018) Heart failure: Macrophages promote cardiac fibrosis and diastolic dysfunction. Nat Rev Cardiol 15:196–197. https://doi.org/10.1038/nrcardio.2018.19CrossRefPubMed

67.

Bartlett R, Stokes L, Sluyter R (2014) The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease. Pharmacol Rev 66:638–675. https://doi.org/10.1124/pr.113.008003CrossRefPubMed

68.

Thériault O, Poulin H, Thomas GR, Friesen AD, Al-Shaqha WA, Chahine M (2014) Pyridoxal-5′-phosphate (MC-1), a vitamin B6 derivative, inhibits expressed P2X receptors. Can J Physiol Pharm 92:189–196. https://doi.org/10.1139/cjpp-2013-0404CrossRef

69.

Kumrungsee T, Zhang P, Chartkul M, Yanaka N, Kato N (2020) Potential Role of Vitamin B6 in Ameliorating the Severity of COVID-19 and Its Complications. Front Nutr 7:562051. https://doi.org/10.3389/fnut.2020.562051CrossRefPubMedPubMedCentral

70.

Huang J, Wang T, Yu D, Fang X, Fan H, Liu Q et al (2018) l-Homocarnosine attenuates inflammation in cerebral ischemia-reperfusion injury through inhibition of nod-like receptor protein 3 inflammasome. Int J Biol Macromol 118:357–364. https://doi.org/10.1016/j.ijbiomac.2018.06.032CrossRefPubMed

71.

Dai Z, Lu XY, Zhu WL, Liu XQ, Li BY, Song L et al (2020) Carnosine ameliorates age-related dementia via improving mitochondrial dysfunction in SAMP8 mice. Food Funct 1:2489–2497. https://doi.org/10.1039/c9fo02453kCrossRef

Titel: Emerging cardioprotective mechanisms of vitamin B6: a narrative review
verfasst von: Thanutchaporn Kumrungsee
Peipei Zhang
Noriyuki Yanaka
Takashi Suda
Norihisa Kato
Publikationsdatum: 26.08.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nutrition / Ausgabe 2/2022
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-021-02665-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2022

Interplay between adipose tissue secreted proteins, eating behavior and obesity

Boron Intake and decreased risk of mortality in kidney transplant recipients

Relationship of maternal obesity and vitamin D concentrations with fetal growth in early pregnancy

Changes in patterns of take-away food ordering among youths before and after COVID-19 lockdown in China: the COVID-19 Impact on Lifestyle Change Survey (COINLICS)

Effects of β-glucan, probiotics, and synbiotics on obesity-associated colitis and hepatic manifestations in C57BL/6J mice